According to ImmunoGen 's latest financial reports the company's current EPS (TTM) is -$0.31. In 2022 the company made an earnings per share (EPS) of -$0.88 a decrease over its 2021 EPS that were of -$0.67.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.31 | -64.77% |
2022 | -$0.88 | 31.34% |
2021 | -$0.67 | 148.15% |
2020 | -$0.27 | -61.97% |
2019 | -$0.71 | -41.32% |
2018 | -$1.21 | 18.63% |
2017 | -$1.02 | -42.7% |
2016 | -$1.78 | 29.93% |
2015 | -$1.37 | 61.18% |
2014 | -$0.85 | 129.73% |
2013 | -$0.37 | -66.96% |
2012 | -$1.12 | 27.27% |
2011 | -$0.88 | 7.32% |
2010 | -$0.82 | 7.89% |
2009 | -$0.76 | -16.48% |
2008 | -$0.91 | 133.33% |
2007 | -$0.39 | -13.33% |
2006 | -$0.45 | 25% |
2005 | -$0.36 | 176.92% |
2004 | -$0.13 | -68.29% |
2003 | -$0.41 | -14.58% |
2002 | -$0.48 | 118.18% |
2001 | -$0.22 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | -4,643.65% | ๐บ๐ธ USA |
Novartis NVS | $3.74 | -1,306.45% | ๐จ๐ญ Switzerland |
Pfizer PFE | $1.86 | -700.00% | ๐บ๐ธ USA |
Eli Lilly LLY | $5.43 | -1,851.38% | ๐บ๐ธ USA |
Amgen AMGN | $14.15 | -4,664.52% | ๐บ๐ธ USA |
Sanofi SNY | $3.18 | -1,125.89% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $3.97 | -1,380.65% | ๐บ๐ธ USA |
Seagen
SGEN | -$4.01 | 1,193.55% | ๐บ๐ธ USA |